Work

Triple Gene-Modified iPSC-Derived NK Cells Combined with Daratumumab for Targeted Immunotherapy Against AML

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-137138

Authors: Frank Cichocki, Ryan Bjordahl, Karrune Woan, Zachary Davis, Greg Bonello, Sajid Mahmood, Paul Rogers, Moyar Q. Ge, Tom Lee, Martin Felices, Bruce Walcheck, Bruce R. Blazar, Bahram Valamehr, Jeffrey S. Miller

Institutions: University of Minnesota, Fate Therapeutics (United States), Masonic Cancer Center

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096181554

FWCI:

Cites:

Cited by: 1

Related to: 10